Abstract
As soon as it is medically justifiable, cryopreserved gametes or the cryopreserved gonadal tissue can be thawed. Sperm are used either for intrauterine insemination or IVF/ICSI therapy. The birth rate per patient is approximately 50%. If oocytes had been cryopreserved, the birth rates are about 35% if all frozen oocytes are transferred after fertilization. Ovarian tissue is transplanted orthotopically, which leads to birth rates of approximately 25% according to current data. If IVF/ICSI therapy is carried out treatment require modifications due to the frequently very low ovarian reserve after gonadotoxic therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
von Wolff M, Haaf T. In vitro fertilization technology and child health—risks, mechanisms and possible consequences. Dtsch Arztebl Int. 2020;117:23–30.
Meistrich ML, Byrne J. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer treated with potentially mutagenic therapies. Am J Hum Genet. 2002;70:1069–71.
Cobo A, García-Velasco JA, Domingo J, Pellicer A, Remohí J. Elective and onco-fertility preservation: factors related to IVF outcomes. Hum Reprod. 2018;33:2222–31.
Diaz-Garcia C, Domingo J, Garcia-Velasco JA, Herraiz S, Mirabet V, Iniesta I, et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril. 2018;109:478–85.e2.
Van der Ven H, Liebenthron J, Beckmann M, Toth B, Korell M, Krüssel J, et al. FertiPROTEKT network. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod. 2016;31:2031–41.
Jadoul P, Guilmain A, Squifflet J, Luyckx M, Votino R, Wyns C, et al. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases. Hum Reprod. 2017;32:1046–54.
Ferrari S, Paffoni A, Filippi F, Busnelli A, Vegetti W, Somigliana E. Sperm cryopreservation and reproductive outcome in male cancer patients: a systematic review. Reprod Biomed Online. 2016;33:29–38.
Wainer R, Albert M, Dorion A, Bailly M, Bergère M, Lombroso R, et al. Influence of the number of motile spermatozoa inseminated and of their morphology on the success of intrauterine insemination. Hum Reprod. 2004;19:2060–5.
Cao S, Zhao C, Zhang J, Wu X, Zhou L, Guo X, et al. A minimum number of motile spermatozoa are required for successful fertilisation through artificial intrauterine insemination with husband’s spermatozoa. Andrologia. 2014;46:529–34.
Gubert PG, Pudwell J, Van Vugt D, Reid RL, Velez MP. Number of motile spermatozoa inseminated and pregnancy outcomes in intrauterine insemination. Fertil Res Pract. 2019;5:10.
Ghobara T, Gelbaya TA, Ayeleke RO. Cycle regimens for frozen-thawed embryo transfer. Cochrane Database Syst Rev. 2017;7:CD003414.
Meirow D, Ra’anani H, Shapira M, Brenghausen M, Derech Chaim S, Aviel-Ronen S, et al. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria. Fertil Steril. 2016;106:467–74.
Fortin A, Azaïs H, Uzan C, Lefebvre G, Canlorbe G, Poirot C. Laparoscopic ovarian tissue harvesting and orthotopic ovarian cortex grafting for fertility preservation: less is more. Fertil Steril. 2019;111:408–10.
von Wolff M. The role of natural cycle IVF in assisted reproduction. Best Pract Res Clin Endocrinol Metab. 2019;33:35–45.
Gook D, Hale L, Polyokov A, Stern K. Outcomes from heterotopic and orthotopic grafting of human cryopreserved ovarian tissue. Hum Reprod. 2019;34(Suppl):i60–1.
Kohl Schwartz, A, Calcaferri I, Roumet M, Fink A, Wuuest A, Weidlinger S et al. Follicular flushing leads to higher oocyte yield in monofollicular natural cycle IVF – a prospective randomized controlled trial. Hum Reprod, in press.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
von Wolff, M. (2020). Fertility Treatment After Fertility Preservation Therapies. In: von Wolff, M., Nawroth, F. (eds) Fertility Preservation in Oncological and Non-Oncological Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-47568-0_29
Download citation
DOI: https://doi.org/10.1007/978-3-030-47568-0_29
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-47567-3
Online ISBN: 978-3-030-47568-0
eBook Packages: MedicineMedicine (R0)